CLADRIBINE
Manner of administration:Oral
Restriction (Streamlined authority code: 16345)
Indication: Relapsing remitting multiple sclerosis
Treatment phase: Initial treatment
Restriction (Streamlined authority code: 16299)
Indication: Relapsing remitting multiple sclerosis
Treatment phase: Continuing treatment
